| 27.52 Delayed Data As of Jun 25 |  +0.02 / +0.07%Today’s Change | 10.41 Today|||52-Week Range 28.46 | +121.58% Year-to-Date |
| Previous close | 27.50 |
| Today’s open | 27.69 |
| Day’s range | 27.24 - 27.90 |
| Volume | 1,483,692 |
| Average volume (3 months) | 1,944,977 |
| Market cap | $2.7B |
| Earnings growth (last year) | -38.51% |
| Earnings growth (this year) | +201.85% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -48.60% |
| P/E ratio | 393.1 |
| Price/Sales | 99.33 |
| Price/Book | 25.99 |
| Today’s change | Today’s % change | |
|---|---|---|
| MEDPMedpace Holdings Inc | +0.32 | +0.52% |
| RGNXRegenxbio Inc | +0.15 | +0.30% |
| FGENFibroGen Inc | -1.27 | -2.92% |
| CDXSCodexis Inc | -0.31 | -1.65% |
| Next reporting date | August 7, 2019 |
| EPS forecast (this quarter) | $0.24 |
| Annual revenue (last year) | $16.1M |
| Annual profit (last year) | -$54.5M |
| Net profit margin | -337.32% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Christopher Richard Anzalone |
Chief Operating Officer Bruce D. Given |
Corporate headquarters Pasadena, California |
